Sequoia Capital related stories
All articles and analysis
Sequoia invests $25m in Chicago's Mu-SigmaUsing capital from both India and US growth funds, the firm has taken an undisclosed stake in the FTV Capital-backed analytics service provider.
- E-commerce hot pick for Sequoia
Venture capital firm Sequoia Capital has made another investment in China’s e-commerce sector, investing an undisclosed amount into apparel retailer Milanoo.com.
- Qihoo plans $200m NYSE IPO
CDH, Sequoia, Highland Capital and Redpoint Ventures are among the firms that invested around $39 million in the Chinese internet company.
- PEI Awards winners find success in uncertain times
During December, thousands of private equity industry participants in more than 50 countries took the time to think about which firms, advisors and transactions truly stood out from the rest in 2010. They voted in our annual PEI Awards readers’ poll, the results of which were revealed this week and highlight the fact that the brightest firms in the industry have flourished despite challenging conditions.
- Sequoia promotes Steven Ji to partner
Shanghai-based Ji joined Sequoia in 2005 as managing director. He has led deals including Comsenz and Country Style Cooking.
- Sequoia India loses senior VCs
Four managing directors who established Sequoia's presence in the country in 2006 have quit to return to public equity investing.
- Indian exits reach record high in 2010
Private equity firms exited a record 121 companies in India during 2010, while investments almost doubled to $7.97bn from the 2009 figure, according to recent data.
- Futher funding for TA Associates-backed mobile phone maker
Sequoia Capital, Sandstone Capital and Madison India have bought a minority stake in Delhi-based Micromax Informatics. TA Associates acquired a 10% stake in the company in January this year.
- TA Associates buys 16% of Indian pathology company
The US-headquartered firm bought a portion of its stake in Delhi-based Dr Lal Pathlabs from previous investor Sequoia Capital.
- Report: Suitors found for Sequoia and Actis' Paras
Morgan Stanley has reportedly found five potential trade buyers for the firms' 70% stake in Paras Pharmaceuticals, which is valued at $700m.